PRESS RELEASE
8 November 2023

Biosimilars Patent Challenges At The PTAB: Update And Lessons Learned

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
On November 14, 2023, in the third webinar in Goodwin’s 2023 Biosimilars Webinar Series, Goodwin IP Litigation partner and managing editor of the Goodwin PTAB
United States
To print this article, all you need is to be registered or login on Mondaq.com.

On November 14, 2023, in the third webinar in Goodwin's 2023 Biosimilars Webinar Series, Goodwin IP Litigation partner and managing editor of the Goodwin PTAB Trial Tracker newsletter, Linnea Cipriano, Goodwin IP Litigation associate and Big Molecule Watch editor, James Breenand Goodwin IP Litigation associate, Christine Potkay, will provide an update to Goodwin's May 2020 webinar regarding Biosimilar challenges at the PTAB. This webinar will explore topics including:

  • Evolving trends of biologic patent challenges at the PTAB;
  • Strategic considerations for biosimilar manufacturers; and
  • Lessons learned from recent filings.

Click here to register for the webinar.

CLE credit will be offered for California, Minnesota, New Jersey, New York and Pennsylvania.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

PRESS RELEASE
8 November 2023

Biosimilars Patent Challenges At The PTAB: Update And Lessons Learned

United States

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More